• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.32% Nasdaq Down0.06%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    35.21 Down 0.35(0.98%) 2:41PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 77,498   2,637   42,051   2,160  
    Cost of Revenue -   -   -   -  
    Gross Profit 77,498   2,637   42,051   2,160  
    Operating Expenses
    Research Development4,519  5,202  4,553  4,722  
    Selling General and Administrative2,769  2,761  2,603  2,565  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 70,210   (5,326) 34,895   (5,127)
    Income from Continuing Operations
    Total Other Income/Expenses Net303  240  41  (72)
    Earnings Before Interest And Taxes70,513  (5,086)34,936  (5,199)
    Interest Expense2  4  5  4  
    Income Before Tax70,511  (5,090)34,931  (5,203)
    Income Tax Expense28,502  (48)(15,122) -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops42,009  (5,042)50,053  (5,203)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 42,009   (5,042) 50,053   (5,203)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 42,009   (5,042) 50,053   (5,203)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.